Patents matching “immunomodulatory”

US 12102688

Immunomodulatory nanofilaments

Stichting Radboud universitair medisch centrum · Granted Oct 1, 2024 · Expires Sep 26, 2044

US 11702461

T-cell modulatory multimeric polypeptides comprising reduced-affinity immunomodulatory polypeptides

Cue Biopharma, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

US 11696896

Immunomodulatory nanoparticle treatment of brain injury

Northwestern University · Granted Jul 11, 2023 · Expires Jul 6, 2043

US 11571444

Enhancement of MSC immunomodulatory properties by treprostinil

United Therapeutics Corporation · Granted Feb 7, 2023 · Expires Feb 2, 2043

US 2021163596

IMMUNOMODULATORY IL-2 AGENTS IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS

ALKERMES PHARMA IRELAND LTD [IE] · Granted Jun 3, 2021 · Expires May 29, 2041

US 10001483

Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 19, 2018 · Expires Jun 14, 2038

US 9717827

Immunomodulatory materials for implantable medical devices

The Regents of the University of California · Granted Aug 1, 2017 · Expires Jul 27, 2037

US 8618080

Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines

OM PHARMA · Granted Dec 31, 2013 · Expires Dec 26, 2033

US 8557859

Immunomodulatory compositions

Summit (Wales) Limited · Granted Oct 15, 2013 · Expires Oct 10, 2033

US 8383665

Immunomodulatory compositions

Summit (Wales) Limited · Granted Feb 26, 2013 · Expires Feb 21, 2033

US 8309527

Immunomodulatory oligonucleotides

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 13, 2012 · Expires Nov 8, 2032

US 8148340

Immunomodulatory oligonucleotides

The United States of America, as represented by the Department of Health and Human Services · Granted Apr 3, 2012 · Expires Mar 29, 2032

US 8114848

Immunomodulatory oligonucleotides

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 14, 2012 · Expires Feb 9, 2032

US 2012029034

Novel calcium salts of Compound as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents

AMMENDOLA ALDO [DE] · Granted Feb 2, 2012 · Expires Jan 28, 2032

US 7915240

Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines

OM PHARMA · Granted Mar 29, 2011 · Expires Mar 24, 2031

US 7208478

Immunostimulatory polynucleotide/immunomodulatory molecule conjugates

The Regents of the University of California · Granted Apr 24, 2007 · Expires Apr 19, 2027

US 6610661

Immunostimulatory polynucleotide/immunomodulatory molecule conjugates

The Regents of the University of California · Granted Aug 26, 2003 · Expires Aug 21, 2023

US 6562801

PpGpp and pppGpp as immunomodulatory agents

The Board of Regents of the University of Texas System · Granted May 13, 2003 · Expires May 8, 2023

US 6552006

Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen

The United States of America as represented by the Department of Veteran Affairs · Granted Apr 22, 2003 · Expires Apr 17, 2023

US 6271214

Process for the preparation of immunomodulatory polysaccharides from aloe

Univera Pharmaceuticals, Inc. · Granted Aug 7, 2001 · Expires Aug 2, 2021

US 6194388

Immunomodulatory oligonucleotides

The United States of America · Granted Feb 27, 2001 · Expires Feb 22, 2021

US 6133440

Process for the preparation of immunomodulatory polysaccharides from aloe

Univera Pharmaceuticals, Inc. · Granted Oct 17, 2000 · Expires Oct 12, 2020